Jones J E, Nelson E A
North Sefton and West Lancashire Community Trust, Churchtown Community Clinic, 137 Cambridge Road, Southport, Merseyside, UK, PR9 7LT.
Cochrane Database Syst Rev. 2000(2):CD001737. doi: 10.1002/14651858.CD001737.
Venous leg ulceration is a common, recurring, disabling condition affecting up to 1% of adults. Treatment is aimed at healing with simple dressings and compression bandages / stockings. Unfortunately in some cases this treatment is unsuccessful with ulcers remaining open for months or years. In order to stimulate healing, some clinicians use skin grafts. These skin grafts may be taken from the patients own uninjured skin (e.g. thigh), may be grown from the patient's skin cells into a dressing, (both known as autografts) or applied as a sheet of bioengineered skin grown from a donor cells (known as an allograft). Preserved skin from other animals, e.g. pigs, have also been used and these are known as xerografts.
To assess the effectiveness of skin grafts in the treatment of venous leg ulcers.
We searched the Cochrane Wounds Groups specialised register (date of search October 1999), and reference lists of relevant articles. We hand searched relevant journals and conference proceedings, and contacted experts in the field.
Randomised controlled trials evaluating skin grafts in the treatment of venous leg ulcers. There was no restriction on articles based on language or publication status.
Data extraction and assessment of study quality was undertaken by two reviewers independently. Trials with similar patients, comparisons, and outcomes were pooled.
Seven RCTs of skin grafts for venous leg ulcers were identified. In 6 trials patients also received compression bandaging. Two trials (98 patients) evaluated split thickness autografts, three trials (92 patients) evaluated cultured keratinocyte allografts, one compared tissue engineered skin (artificial skin) with a dressing (309 patients) and one compared it with a split thickness skin graft (7 patients, 13 ulcers). The trials comparing artificial skin with a dressing reported a significantly higher proportion of ulcers healing with artificial skin. There was insufficient evidence from the remaining trials to determine whether other types of skin grafting increased the healing of venous ulcers.
REVIEWER'S CONCLUSIONS: There is limited evidence that artificial skin used in conjunction with compression bandaging, increases the chance of healing a venous ulcer compared to compression alone. Further research is needed to assess whether other forms of skin grafts increase ulcer healing.
下肢静脉溃疡是一种常见的、复发性的、致残性疾病,影响着高达1%的成年人。治疗旨在通过简单的敷料和加压绷带/弹力袜促进愈合。不幸的是,在某些情况下,这种治疗并不成功,溃疡会持续数月或数年不愈合。为了促进愈合,一些临床医生使用皮肤移植。这些皮肤移植可以取自患者自身未受伤的皮肤(如大腿),可以从患者的皮肤细胞培养成敷料(两者都称为自体移植),或者作为从供体细胞培养的生物工程皮肤片应用(称为同种异体移植)。来自其他动物(如猪)的保存皮肤也被使用,这些被称为异种移植。
评估皮肤移植治疗下肢静脉溃疡的有效性。
我们检索了Cochrane伤口小组专门注册库(检索日期为1999年10月)以及相关文章的参考文献列表。我们手工检索了相关期刊和会议论文集,并联系了该领域的专家。
评估皮肤移植治疗下肢静脉溃疡的随机对照试验。对基于语言或发表状态的文章没有限制。
由两名评价员独立进行数据提取和研究质量评估。对具有相似患者、对照和结局的试验进行汇总。
确定了7项关于皮肤移植治疗下肢静脉溃疡的随机对照试验。在6项试验中,患者还接受了加压包扎。两项试验(98例患者)评估了中厚自体皮片移植,三项试验(92例患者)评估了培养的角质形成细胞同种异体移植,一项试验将组织工程皮肤(人工皮肤)与一种敷料进行比较(309例患者),另一项试验将其与中厚皮片移植进行比较(7例患者,13处溃疡)。将人工皮肤与敷料进行比较的试验报告显示,使用人工皮肤愈合的溃疡比例明显更高。其余试验提供的证据不足以确定其他类型的皮肤移植是否能提高静脉溃疡的愈合率。
证据有限,与单纯加压包扎相比,人工皮肤联合加压包扎可增加下肢静脉溃疡愈合的机会。需要进一步研究以评估其他形式的皮肤移植是否能促进溃疡愈合。